>アジア太平洋地域の肺がんスクリーニングソフトウェア市場、配信モード別（クラウドベースのソリューション、オンプレミスソリューション、Webベースのソリューション）、製品別（肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節のコンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニングPAC、診療管理と監査ログ追跡）、タイプ別（コンピューター支援スクリーニングと従来のスクリーニング）、アプリケーション別（非小細胞肺がん（NSCLC）と小細胞肺がん（SCLC））、プラットフォーム別（スタンドアロンと統合）、購入モード別（機関および個人）、エンドユーザー別（腫瘍学センター、病院、外来手術センターなど）、流通チャネル別（直接入札とサードパーティ販売業者） - 2029年までの業界動向と予測。
アジア太平洋地域の肺がんスクリーニングソフトウェア市場の分析と洞察
肺がんによる死亡率の抑制は、医療施設にとって大きな懸念事項の 1 つです。公的機関や民間組織は、死亡率を抑制するためのスクリーニング プログラムを開始する取り組みを行っています。さらに、企業は、患者のデータの管理を容易にし、厳格なデータ プライバシー ガイドラインに従ってより良いケアを提供するための高度なソフトウェアを導入しています。
肺がんの罹患率の増加、肺がんに対する人々の意識の高まり、政府の取り組みの増加、スクリーニング プログラムの増加は、市場の成長を牽引する主な要因の一部です。さらに、人工知能 (AI) ベースのソリューションの進歩と主要な市場プレーヤーによる戦略的取り組みにより、肺がんスクリーニング ソフトウェアの分野で機会が生まれています。
しかし、データプライバシーの問題と非熟練労働者の不足が、予測期間中の市場の成長を妨げると予想されます。
Data Bridge Market Research の分析によると、アジア太平洋地域の肺がんスクリーニング ソフトウェア市場は、予測期間中に 20.8% の CAGR で成長し、2029 年までに 14,981.84 千米ドルに達すると予想されています。クラウド ベースのソリューションは、市場における最大の配信モード セグメントを占めています。市場レポートでは、価格分析、特許分析、技術進歩についても詳細に取り上げています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2022年から2029年 |
|
基準年 |
2021 |
|
歴史的な年 |
2020 (2019～2014 にカスタマイズ可能) |
|
定量単位 |
収益は1000米ドル、価格は米ドル |
|
対象セグメント |
提供方法（クラウドベースのソリューション、オンプレミスソリューション、Web ベースのソリューション）、製品（肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節のコンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニング PAC、診療管理と監査ログ追跡）、タイプ（コンピューター支援スクリーニングと従来のスクリーニング）、アプリケーション（非小細胞肺がん（NSCLC）と小細胞肺がん（SCLC）、プラットフォーム（スタンドアロンと統合）、購入モード（機関と個人）、エンドユーザー（腫瘍学センター、病院、外来手術センターなど）、流通チャネル（直接入札とサードパーティの販売業者） |
|
対象国 |
中国、韓国、日本、インド、オーストラリア、シンガポール、マレーシア、インドネシア、タイ、フィリピン、およびその他のアジア太平洋諸国。 |
|
対象となる市場プレーヤー |
PenRad Technologies Inc.、Koninklijke Philips NV、Volpara Health Limited、Thynk Health、Nuance Communications, Inc.、Siemens Healthcare GmbH、MyCareWare, Inc.、MagView、MeVis Medical Solutions AG、Canon Medical Informatics, Inc.、General Electric Company、Epic Systems Corporation、Lungview、Eon、Medtronic、Coreline Soft Co., Ltd.、Optellum Ltd、HealthMyne、Oncocyte Corporation、Genesystem、REVEALDX、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche Ltd、Median Technologies、AstraZeneca、Aidence.com |
市場の定義
肺がんスクリーニングは、さまざまな技術とソフトウェアを使用して肺がんの段階を特定します。CT を使用した肺がんスクリーニングは、肺がんのスクリーニングに最も推奨される技術です。この技術の使用が増えると、肺がんスクリーニング用の高度なソフトウェアの必要性が加速すると予想されます。このソフトウェアは、肺スクリーニング プログラムへの患者の参加を管理するのに役立ち、医療専門家がデータを収集、整理し、臨床医と患者に転送するための効率的な方法を提供します。さらに、このソフトウェアは、リスクのある患者を特定し、統合された電子健康記録を使用してデータの流れを自動化します。
アジア太平洋地域の肺がんスクリーニングソフトウェア市場の動向
このセクションでは、市場の推進要因、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。
ドライバー
- 世界的に肺がんの罹患率が増加
肺がんは、男性と女性の両方で死亡の主な原因です。世界がん研究基金インターナショナルによると、肺がんは世界で2番目に多いがんです。男性では最も一般的ながんで、女性では2番目に多いがんです。2020年には、2,200件を超える肺がんの新規症例がありました。肺がん症例の増加により、早期診断のための肺がんスクリーニングソフトウェアの導入の必要性が生まれ、市場成長の原動力となっています。
- 早期診断と頻繁な検査の利点に関する認識の向上
公的機関、非営利組織、民間組織による肺がんの啓発プログラムの高まりが、市場の成長を後押しすると予想されています。これらの取り組みは、病気を予防し、偏見や汚名を減らし、研究を促進することを目的としています。肺がんに関する国民の意識は高まっています。さまざまな組織による啓発プログラムが多数あるため、早期に診断されれば治癒できる肺がんについて人々は知っています。このように、国民の意識向上が市場の成長を牽引しています。
- さまざまな病気の検査プログラムを実施するための政府の取り組みが行われた。
がんの負担は世界的に増加し続けており、医療制度、製品、家族、個人に大きな経済的、感情的、身体的ストレスを与えています。医療制度が充実した国では、生存率、質の高いケア、意識の向上、早期発見の容易さにより、多くの種類のがんの生存率が向上しています。米国疾病予防管理センター、部族、米国太平洋諸島および領土は、国家包括的がん対策プログラム (NCCCP) を通じて、地域社会でがんと闘うための同盟を結成または支援することになっています。これらの取り組みにより、より多くの聴衆が教育を受け、より意識的に分散し、世界中の聴衆がさらなる予防策を講じ、予防検査を実践するよう促され、市場が促進されます。
- 世界中でスクリーニングプログラムが増加
スクリーニングは、がんの早期発見に効果的な方法です。発展途上国では肺がんの発生率が増加傾向にあります。乳がんや子宮頸がんのスクリーニングには定期的な推奨がありますが、肺がんの場合は同じではありません。ほとんどの国や機関は、肺がんに対する低線量コンピューター断層撮影（LDCT）の実現可能性と疾患スクリーニングを開始しています。肺がんスクリーニングの増加は、市場プレーヤーにチャンスを生み出しています。したがって、診断率の増加は市場成長の原動力として機能します。
機会
-
市場参加者間のコラボレーション、合併、買収の増加
市場で事業を展開している企業は、合併や買収、製品の発売、契約、パイプラインの開発、コラボレーション、市場拡大など、さまざまな戦略を採用して、さまざまな側面でビジネスを拡大しています。企業によるこれらの戦略的決定は、市場で事業を展開している市場プレーヤーに大きな機会を提供することが期待されています。
抑制/挑戦
- ソフトウェアの可用性に関する問題
発展途上国における肺がんスクリーニングの有効性と効率性、および肺がんスクリーニングソフトウェアの可用性に関連する特定の問題/障壁があります。問題とは、時間に対する競合する要求、肺がんスクリーニングに関する知識、スクリーニングの有効性に関する変化する態度、歴史的に貧弱な肺がん治療結果に関連する虚無主義、地方自治体または国の医療機器規制機関に対するトレーニングと要件の承認の制限です。これらすべての問題により、製品の発売と可用性が遅れます。また、肺がんスクリーニングソフトウェアの需要は、利用可能なソフトウェアに関連する技術的な問題によって妨げられ、市場の成長の抑制要因となっています。
COVID-19後のアジア太平洋地域の肺がんスクリーニングソフトウェア市場への影響
COVID-19は、ほぼすべての国が必需品を扱う施設を除くすべての施設の閉鎖を選択したため、さまざまな業界に大きな影響を与えました。政府は、COVID-19の拡散を防ぐために、施設の閉鎖や非必需品の販売、国際貿易の遮断など、いくつかの厳しい措置を講じました。このパンデミックの状況下で運営されていた唯一のビジネスは、開業とプロセスの運営が許可された必須サービスでした。
COVID-19 は、医療提供者が患者ケアを提供する上で、新たな未知の課題を生み出しました。肺がんスクリーニングなど、必須ではないが重要なサービスの多くは、スタッフと患者の健康を守るために一時的に中断されました。医療機関は、COVID-19 中のケアの継続性を確保し、サービスを安全に継続できるようにするために、スケジュール設定、患者のモニタリング、患者とサービスのコミュニケーションのフォローアップに関して前例のない課題に直面しました。COVID-19 は肺がんスクリーニング プログラムに新たな課題を生み出し、多くの場合、スクリーニングが数か月遅れ、管理およびスケジュール設定チームにとってさらに困難が生じました。COVID-19 危機は呼吸補助の重要性に新たな光を当てましたが、がんスクリーニングの偏見を減らすことに大きな影響を与えることを期待しています。米国には肺がんスクリーニングの対象となる適格患者が 10,000,000 人以上いますが、スクリーニング プログラムに積極的に登録しているのはそのうちの 5% 未満です。COVID-19 は市場に悪影響を及ぼしました。
しかし、肺がんスクリーニングソフトウェア企業は苦戦しており、状況をコントロールするためにさまざまな戦略的決定を継続的に行っています。プレーヤーは、市場に関連する技術を向上させるために、パートナーシップ、コラボレーション、合併や買収などの戦略的活動に関与しています。これにより、企業は市場に高度で正確なソリューションをもたらします。さらに、業界全体のデジタル化を促進する政府の取り組みも市場の成長につながっています。
最近の動向
- GEヘルスケアは2022年7月、最新製品であり最先端の超音波装置である次世代のVoluson Expert 22を発売しました。GEヘルスケアの受賞歴のある女性の健康ポートフォリオに新たに加わったこの製品は、グラフィックベースのビームフォーマー技術を採用しており、より高品質の画像を生成し、画像機能の柔軟性を高めています。この製品により、同社は医療機関向けの製品およびサービスプロバイダーの分野での地位をさらに強化しました。
- 2021年10月、Thynk Healthは、世界最先端の技術で肺がんと闘うためにInfervisionとの提携を発表しました。肺がんのスクリーニングと肺結節の管理の機会を提供します。この提携により、同社は市場での存在感を高めました。
アジア太平洋地域の肺がんスクリーニングソフトウェア市場の範囲
アジア太平洋地域の肺がんスクリーニング ソフトウェア市場は、配信モード、製品、タイプ、アプリケーション、プラットフォーム、購入モード、エンド ユーザー、および流通チャネルに基づいて、8 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界のわずかな成長セグメントの分析に役立ち、ユーザーに貴重な市場の概要と市場の洞察を提供し、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。
配送方法
- クラウドベースのソリューション
- オンプレミスソリューション
- ウェブベースのソリューション
配信モードに基づいて、市場はクラウドベースのソリューション、オンプレミスソリューション、Web ベースのソリューションに分類されます。
製品
- 肺がんスクリーニング放射線ソリューション
- 肺がんスクリーニング患者管理ソフトウェア
- 結節管理ソフトウェア
- データ収集とレポート
- 患者の調整とワークフロー
- 肺結節のコンピュータ支援検出
- 病理学と癌のステージ分類
- 統計監査報告
- スクリーニングPACS
- 実務管理
- 監査ログの追跡
製品に基づいて、市場は、肺がんスクリーニング放射線ソリューション、肺がんスクリーニング患者管理ソフトウェア、結節管理ソフトウェア、データ収集とレポート、患者調整とワークフロー、肺結節コンピューター支援検出、病理学とがんのステージング、統計監査レポート、スクリーニングPACS、診療管理、および監査ログ追跡に分類されます。
タイプ
- コンピュータ支援スクリーニング
- 従来のスクリーニング
タイプに基づいて、市場はコンピューター支援スクリーニングと従来のスクリーニングに分類されます。
応用
- 非小細胞肺がん（NSCLC）
- 小細胞肺がん（SCLC）
用途に基づいて、市場は非小細胞肺がん (NSCLC) と小細胞肺がん (SCLC) に分類されます。
プラットフォーム
- スタンドアロン
- 統合された
プラットフォームに基づいて、市場はスタンドアロンと統合に分割されます。
購入モード
- 機関
- 個人
購入モードに基づいて、市場は個人と機関に分割されます。
エンドユーザー
- 腫瘍学センター
- 病院
- 外来手術センター
- その他
エンドユーザーに基づいて、市場は病院、腫瘍学センター、外来手術センター、その他に分類されます。
流通チャネル
- 直接入札
- サードパーティ販売業者
流通チャネルに基づいて、市場は直接入札とサードパーティの販売業者に分割されます。
アジア太平洋地域の肺がんスクリーニングソフトウェア市場の地域分析/洞察
アジア太平洋地域の肺がんスクリーニングソフトウェア市場を分析し、上記の配信モード、製品、タイプ、アプリケーション、プラットフォーム、購入モード、エンドユーザー、および流通チャネルに基づいて市場規模の洞察と傾向を提供します。
この市場に含まれる国は、中国、韓国、日本、インド、オーストラリア、シンガポール、マレーシア、インドネシア、タイ、フィリピン、およびその他のアジア太平洋諸国です。肺がんの症例の増加、支出の増加、市場の大幅な成長につながった医療インフラへの注目の高まりなどの要因により、中国が市場を支配すると予想されています。
この市場レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される重要な指標の一部です。また、国別データの予測分析を提供する際には、アジア太平洋ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
競争環境とアジア太平洋地域の肺がんスクリーニングソフトウェア市場シェア分析
アジア太平洋地域の肺がんスクリーニング ソフトウェア市場の競争状況では、競合他社の詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、アジア太平洋地域でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、ソリューションの導入、製品の幅広さと幅広さ、アプリケーションの優位性などが含まれます。提供されている上記のデータ ポイントは、市場に関連する会社にのみ関連しています。
この市場で活動している主要企業としては、PenRad Technologies Inc.、Koninklijke Philips NV、Volpara Health Limited、Thynk Health、Nuance Communications, Inc.、Siemens Healthcare GmBH、MyCareWare, Inc.、MagView、MeVis Medical Solutions AG、Canon Medical Informatics, Inc.、General Electric Company、Epic Systems Corporation、Lungview、Eon、Medtronic、Coreline Soft, Co., Ltd.、Optellum Ltd、HealthMyne、Oncocyte Corporation、Genesystem、REVEALDX、FUJIFILM Holdings Corporation、F. Hoffmann-La Roche Ltd、Median Technologies、AstraZeneca、Aidence.com などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATIONS & REIMBURSEMENT
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF LUNG CANCER CASES ASIA PACIFICLY
6.1.2 INCREASE IN AWARENESS REGARDING THE BENEFITS OF EARLY DIAGNOSIS AND FREQUENT SCREENING
6.1.3 GOVERNMENT INITIATIVES WERE UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
6.1.4 GROWING NUMBER OF SCREENING PROGRAMS ACROSS THE GLOBE
6.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
6.2 RESTRAINTS
6.2.1 ISSUES RELATED TO THE AVAILABILITY OF SOFTWARE
6.2.2 SCARCITY OF TECHNICALLY KNOWLEDGEABLE PROFESSIONALS FOR CANCER DIAGNOSIS
6.2.3 LACK OF FUNDING AND OTHER RESOURCES FROM VARIOUS REGIONS FOR CANCER AND ASSOCIATED DISORDERS
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATIONS, MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS
6.3.2 INCREASING INVESTMENTS IN HEALTHCARE SEGMENTS
6.3.3 MULTIPLE BENEFITS ASSOCIATED WITH LUNG CANCER SCREENING SOFTWARE
6.4 CHALLENGES
6.4.1 HIGH COST OF SCREENING SOFTWARE AND RELATED SERVICES
6.4.2 INCREASING CHALLENGES RELATED TO THE DEVELOPMENT OF LUNG CANCER SCREENING SOFTWARE
6.4.3 INCREASING COMPETITION IN THE MARKET
7 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY
7.1 OVERVIEW
7.2 CLOUD BASED SOLUTIONS
7.3 ON-PREMISE SOLUTIONS
7.4 WEB BASED SOLUTIONS
8 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 LUNG CANCER SCREENING RADIOLOGY SOLUTION
8.2.1 ON-PREMISE SOLUTIONS
8.2.2 WEB BASED SOLUTIONS
8.2.3 CLOUD BASED SOLUTIONS
8.3 LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE
8.3.1 CLOUD BASED SOLUTIONS
8.3.2 ON-PREMISE SOLUTIONS
8.3.3 WEB BASED SOLUTIONS
8.4 NODULE MANAGEMENT SOFTWARE
8.4.1 CLOUD BASED SOLUTIONS
8.4.2 ON-PREMISE SOLUTIONS
8.4.3 WEB BASED SOLUTIONS
8.5 DATA COLLECTION AND REPORTING
8.5.1 CLOUD BASED SOLUTIONS
8.5.2 WEB BASED SOLUTIONS
8.5.3 ON-PREMISE SOLUTIONS
8.6 PATIENT COORDINATION AND WORKFLOW
8.6.1 CLOUD BASED SOLUTIONS
8.6.2 ON-PREMISE SOLUTIONS
8.6.3 WEB BASED SOLUTIONS
8.7 LUNG NODULE COMPUTER AIDED DETECTION
8.7.1 ON-PREMISE SOLUTIONS
8.7.2 CLOUD BASED SOLUTIONS
8.7.3 WEB BASED SOLUTIONS
8.8 PATHOLOGY AND CANCER STAGING
8.8.1 CLOUD BASED SOLUTIONS
8.8.2 ON-PREMISE SOLUTIONS
8.8.3 WEB BASED SOLUTIONS
8.9 STATISTICAL AUDIT REPORTING
8.9.1 CLOUD BASED SOLUTIONS
8.9.2 ON-PREMISE SOLUTIONS
8.9.3 WEB BASED SOLUTIONS
8.1 SCREENING PACS
8.10.1 CLOUD BASED SOLUTIONS
8.10.2 ON-PREMISE SOLUTIONS
8.10.3 WEB BASED SOLUTIONS
8.11 PRACTICE MANAGEMENT
8.11.1 CLOUD BASED SOLUTIONS
8.11.2 ON-PREMISE SOLUTIONS
8.11.3 WEB BASED SOLUTIONS
8.12 AUDIT LOG TRACKING
8.12.1 CLOUD BASED SOLUTIONS
8.12.2 ON-PREMISE SOLUTIONS
8.12.3 WEB BASED SOLUTIONS
9 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE
9.1 OVERVIEW
9.2 COMPUTER-ASSISTED SCREENING
9.2.1 CLOUD BASED SOLUTIONS
9.2.2 ON-PREMISE SOLUTIONS
9.2.3 WEB BASED SOLUTIONS
9.3 TRADITIONAL SCREENING
9.3.1 CLOUD BASED SOLUTIONS
9.3.2 ON-PREMISE SOLUTIONS
9.3.3 WEB BASED SOLUTIONS
10 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 NON-SMALL CELL LUNG CANCER (NSCLC)
10.2.1 CLOUD BASED SOLUTIONS
10.2.2 ON-PREMISE SOLUTIONS
10.2.3 WEB BASED SOLUTIONS
10.3 SMALL CELL LUNG CANCER (SCLC)
10.3.1 CLOUD BASED SOLUTIONS
10.3.2 ON-PREMISE SOLUTIONS
10.3.3 WEB BASED SOLUTIONS
11 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM
11.1 OVERVIEW
11.2 STANDALONE
11.2.1 CLOUD BASED SOLUTIONS
11.2.2 ON-PREMISE SOLUTIONS
11.2.3 WEB BASED SOLUTIONS
11.3 INTEGRATED
11.3.1 CLOUD BASED SOLUTIONS
11.3.2 ON-PREMISE SOLUTIONS
11.3.3 WEB BASED SOLUTIONS
12 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 INSTITUTIONAL
12.3 INDIVIDUAL
13 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER
13.1 OVERVIEW
13.2 ONCOLOGY CENTERS
13.3 HOSPITALS
13.4 AMBULATORY SURGICAL CENTERS
13.5 OTHERS
14 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDERS
14.3 THIRD PARTY DISTRIBUTOR
15 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 CHINA
15.1.3 AUSTRALIA
15.1.4 SOUTH KOREA
15.1.5 INDIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 KONINKLIJKE PHILIPS N.V
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 SIEMENS HEALTHCARE GMBH
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 NUANCE COMMUNICATIONS, INC.
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 GENRAL ELECTRIC (GE HEALTHCARE)
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ONCOCYTE CORPORATION
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENT
18.6 AIDENCE.COM
18.6.1 COMPANY SNAPSHOT
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENT
18.7 ASTRAZENECA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANON MEDICAL INFORMATICS, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 CORELINE SOFT, CO., LTD.
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 EON
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 EPIC SYSTEMS CORPORATION
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 F. HOFFMANN-LA ROCHE LTD
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 GENESYSTEM
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 HEALTHMYNE
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 LUNGVIEW
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MAGVIEW
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 MEDIAN TECHNOLOGIES
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 MEDTRONIC
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 MEVIS MEDICAL SOLUTIONS AG
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENT
18.21 MYCAREWARE INC.
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 OPTELLUM LTD
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 PENRAD TECHNOLOGIES INC.
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 REVEALDX
18.24.1 COMPANY SNAPSHOT
18.24.2 PRODUCT PORTFOLIO
18.24.3 RECENT DEVELOPMENT
18.25 THYNK HEALTH
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
18.26 VOLPARA SOLUTIONS LIMITED
18.26.1 COMPANY SNAPSHOT
18.26.2 REVENUE ANALYSIS
18.26.3 PRODUCT PORTFOLIO
18.26.4 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
表のリスト
TABLE 1 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 2 ASIA PACIFIC CLOUD BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 3 ASIA PACIFIC ON-PREMISE SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 4 ASIA PACIFIC WEB BASED SOLUTIONS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 5 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 6 ASIA PACIFIC LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 7 ASIA PACIFIC LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 8 ASIA PACIFIC LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 9 ASIA PACIFIC LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 ASIA PACIFIC NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 11 ASIA PACIFIC NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 12 ASIA PACIFIC DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 13 ASIA PACIFIC DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 14 ASIA PACIFIC PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 15 ASIA PACIFIC PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 16 ASIA PACIFIC LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 17 ASIA PACIFIC LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 18 ASIA PACIFIC PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 19 ASIA PACIFIC PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 20 ASIA PACIFIC STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 21 ASIA PACIFIC STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 22 ASIA PACIFIC SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 23 ASIA PACIFIC SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 24 ASIA PACIFIC PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 25 ASIA PACIFIC PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 26 ASIA PACIFIC AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 27 ASIA PACIFIC AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 28 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 29 ASIA PACIFIC COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 30 ASIA PACIFIC COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 31 ASIA PACIFIC TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 32 ASIA PACIFIC TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 33 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 34 ASIA PACIFIC NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 35 ASIA PACIFIC NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 36 ASIA PACIFIC SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 37 ASIA PACIFIC SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 38 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 39 ASIA PACIFIC STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 40 ASIA PACIFIC STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 41 ASIA PACIFIC INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 42 ASIA PACIFIC INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 43 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 44 ASIA PACIFIC INSTITUTIONAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 45 ASIA PACIFIC INDIVIDUAL IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 46 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 47 ASIA PACIFIC ONCOLOGY CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 48 ASIA PACIFIC HOSPITALS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 49 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 50 ASIA PACIFIC OTHERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 51 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 52 ASIA PACIFIC DIRECT TENDERS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 53 ASIA PACIFIC THIRD PARTY DISTRIBUTOR IN LUNG CANCER SCREENING SOFTWARE MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 68 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 69 ASIA-PACIFIC COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 71 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 72 ASIA-PACIFIC NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 74 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 75 ASIA-PACIFIC STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 77 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 78 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 80 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 81 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 82 ASIA-PACIFIC LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 83 ASIA-PACIFIC LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 84 ASIA-PACIFIC NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 85 ASIA-PACIFIC DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 86 ASIA-PACIFIC PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 87 ASIA-PACIFIC LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 88 ASIA-PACIFIC PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 89 ASIA-PACIFIC STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 90 ASIA-PACIFIC SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 91 ASIA-PACIFIC PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 92 ASIA-PACIFIC AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 93 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 94 ASIA-PACIFIC COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 95 ASIA-PACIFIC TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 96 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 97 ASIA-PACIFIC NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 98 ASIA-PACIFIC SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 99 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 100 ASIA-PACIFIC STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 101 ASIA-PACIFIC INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 102 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 103 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 104 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 105 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 106 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 107 CHINA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 108 CHINA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 109 CHINA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 110 CHINA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 111 CHINA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 112 CHINA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 113 CHINA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 114 CHINA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 115 CHINA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 116 CHINA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 117 CHINA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 118 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 119 CHINA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 120 CHINA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 121 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 122 CHINA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 123 CHINA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 124 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 125 CHINA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 126 CHINA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 127 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 128 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 129 CHINA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 130 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 131 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 132 AUSTRALIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 133 AUSTRALIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 134 AUSTRALIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 135 AUSTRALIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 136 AUSTRALIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 137 AUSTRALIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 138 AUSTRALIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 139 AUSTRALIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 140 AUSTRALIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 141 AUSTRALIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 142 AUSTRALIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 143 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 144 AUSTRALIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 145 AUSTRALIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 146 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 147 AUSTRALIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 148 AUSTRALIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 149 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 150 AUSTRALIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 151 AUSTRALIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 152 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 153 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 154 AUSTRALIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 155 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 156 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 157 SOUTH KOREA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 158 SOUTH KOREA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 159 SOUTH KOREA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 160 SOUTH KOREA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 161 SOUTH KOREA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 162 SOUTH KOREA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 163 SOUTH KOREA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 164 SOUTH KOREA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 165 SOUTH KOREA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 166 SOUTH KOREA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 167 SOUTH KOREA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 168 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 169 SOUTH KOREA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 170 SOUTH KOREA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 171 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 172 SOUTH KOREA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 173 SOUTH KOREA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 174 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 175 SOUTH KOREA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 176 SOUTH KOREA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 177 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 178 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 179 SOUTH KOREA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 180 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 181 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 182 INDIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 183 INDIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 184 INDIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 185 INDIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 186 INDIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 187 INDIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 188 INDIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 189 INDIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 190 INDIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 191 INDIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 192 INDIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 193 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 194 INDIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 195 INDIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 196 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 197 INDIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 198 INDIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 199 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 200 INDIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 201 INDIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 202 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 203 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 204 INDIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 205 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 206 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 207 SINGAPORE LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 208 SINGAPORE LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 209 SINGAPORE NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 210 SINGAPORE DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 211 SINGAPORE PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 212 SINGAPORE LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 213 SINGAPORE PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 214 SINGAPORE STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 215 SINGAPORE SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 216 SINGAPORE PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 217 SINGAPORE AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 218 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 219 SINGAPORE COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 220 SINGAPORE TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 221 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 222 SINGAPORE NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 223 SINGAPORE SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 224 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 225 SINGAPORE STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 226 SINGAPORE INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 227 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 228 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 229 SINGAPORE LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 230 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 231 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 232 THAILAND LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 233 THAILAND LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 234 THAILAND NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 235 THAILAND DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 236 THAILAND PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 237 THAILAND LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 238 THAILAND PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 239 THAILAND STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 240 THAILAND SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 241 THAILAND PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 242 THAILAND AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 243 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 244 THAILAND COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 245 THAILAND TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 246 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 247 THAILAND NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 248 THAILAND SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 249 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 250 THAILAND STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 251 THAILAND INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 252 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 253 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 254 THAILAND LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 255 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 256 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 257 MALAYSIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 258 MALAYSIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 259 MALAYSIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 260 MALAYSIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 261 MALAYSIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 262 MALAYSIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 263 MALAYSIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 264 MALAYSIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 265 MALAYSIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 266 MALAYSIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 267 MALAYSIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 268 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 269 MALAYSIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 270 MALAYSIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 271 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 272 MALAYSIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 273 MALAYSIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 274 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 275 MALAYSIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 276 MALAYSIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 277 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 278 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 279 MALAYSIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 280 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 281 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 282 INDONESIA LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 283 INDONESIA LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 284 INDONESIA NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 285 INDONESIA DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 286 INDONESIA PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 287 INDONESIA LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 288 INDONESIA PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 289 INDONESIA STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 290 INDONESIA SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 291 INDONESIA PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 292 INDONESIA AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 293 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 294 INDONESIA COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 295 INDONESIA TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 296 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 297 INDONESIA NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 298 INDONESIA SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 299 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 300 INDONESIA STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 301 INDONESIA INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 302 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 303 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 304 INDONESIA LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 305 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
TABLE 306 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 307 PHILIPPINES LUNG CANCER SCREENING RADIOLOGY SOLUTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 308 PHILIPPINES LUNG CANCER SCREENING PATIENT MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 309 PHILIPPINES NODULE MANAGEMENT SOFTWARE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 310 PHILIPPINES DATA COLLECTION AND REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 311 PHILIPPINES PATIENT COORDINATION AND WORKFLOW IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 312 PHILIPPINES LUNG NODULE COMPUTER AIDED DETECTION IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 313 PHILIPPINES PATHOLOGY AND CANCER STAGING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 314 PHILIPPINES STATISTICAL AUDIT REPORTING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 315 PHILIPPINES SCREENING PACS IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 316 PHILIPPINES PRACTICE MANAGEMENT IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 317 PHILIPPINES AUDIT LOG TRACKING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT, 2020-2029 (USD THOUSAND)
TABLE 318 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 319 PHILIPPINES COMPUTER-ASSISTED SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 320 PHILIPPINES TRADITIONAL SCREENING IN LUNG CANCER SCREENING SOFTWARE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 321 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 322 PHILIPPINES NON-SMALL CELL LUNG CANCER (NSCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 323 PHILIPPINES SMALL CELL LUNG CANCER (SCLC) IN LUNG CANCER SCREENING SOFTWARE MARKET, BY APPLICATION, 2020-2029 (USD THOUSAND)
TABLE 324 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 325 PHILIPPINES STANDALONE IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 326 PHILIPPINES INTEGRATED IN LUNG CANCER SCREENING SOFTWARE MARKET, BY PLATFORM, 2020-2029 (USD THOUSAND)
TABLE 327 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY PURCHASE MODE, 2020-2029 (USD THOUSAND)
TABLE 328 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY END USER, 2020-2029 (USD THOUSAND)
TABLE 329 PHILIPPINES LUNG CANCER SCREENING SOFTWARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 330 REST OF ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET, BY MODE OF DELIVERY, 2020-2029 (USD THOUSAND)
図表一覧
FIGURE 1 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING LUNG CANCER SCREENING PROGRAMS IS EXPECTED TO DRIVE THE ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 CLOUD BASED SOLUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET
FIGURE 14 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY, 2021
FIGURE 15 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY PRODUCT, 2021
FIGURE 16 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: TYPE, 2021
FIGURE 17 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY APPLICATION, 2021
FIGURE 18 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY PLATFORM, 2021
FIGURE 19 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY PURCHASE MODE, 2021
FIGURE 20 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY END USER, 2021
FIGURE 21 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 22 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: SNAPSHOT (2021)
FIGURE 23 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2021)
FIGURE 24 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2022 & 2029)
FIGURE 25 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY COUNTRY (2022 & 2029)
FIGURE 26 ASIA-PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: BY MODE OF DELIVERY (2022-2029)
FIGURE 27 ASIA PACIFIC LUNG CANCER SCREENING SOFTWARE MARKET: COMPANY SHARE 2021 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
